B-cell receptor (BCR) repertoire is highly diverse. Repertoire diversity is achieved centrally by somatic recombination of immunoglobulin (Ig) genes and peripherally by somatic hypermutation and class-switching. Throughout these processes there is selection for functional gene rearrangements, selection against gene combinations resulting in self-reactive BCRs and selection for BCRs with high affinity for exogenous antigens after challenge. Hence investigation of BCR repertoires from different groups of B cells can provide information on stages of B cell development and possibly shed light on the aetiology of B cell pathologies. The third complementarity determining region of the Ig heavy chain (CDR-H3) contributes the majority of amino acids to the antibody/antigen binding interface in most instances. Although CDR-H3 spectratype analysis provides information on the overall diversity of BCR repertoires, it is a fairly simple technique that analyses the relative quantities of CDR-H3 regions of each size, within a range of approximately 10-80 bp, without sequence detail and thus is limited in scope. High-throughput sequencing (HTS) techniques on the Roche 454 GS FLX Titanium system however can generate a wide coverage of Ig sequences to provide more qualitative data such as V, D and J usage as well as detailed CDR3 sequences Here we present protocols in detail for CDR-H3 spectratype analysis and HTS of human BCR repertoires.
Introduction
There are a number of processes that contribute to B cell diversity. B cell receptors (BCR), or antibodies, are encoded by two different genes that are formed of rearranged gene segments during B cell development in the bone marrow. Rearrangement of Ig heavy chain genes (IGH), in which variable (IGHV), diversity (IGHD) and joining (IGHJ) genes are randomly selected and spliced together occurs first [1] . During the process of somatic recombination in the IGH, further BCR diversity is introduced by imprecise insertion and deletion of nucleotides at the junctions of the rearranged genes, resulting in the third complementarity determining (CDR-H3) region. The CDR-H3 serves as a genetic fingerprint for an individual B-cell clone throughout its development. There is further random assortment of pairing between the IGH and the light chain genes. These can either be kappa (IGK) or lambda (IGL) genes and are formed as a result of rearrangement of variable and joining regions (either IGKV and IGKJ or IGLV and IGLJ).
The diverse repertoire created by these mechanisms can then be shaped by events external to the cell. Negative selection to remove cells with self-reactive BCRs occurs, and positive selection, to expand cells reactive to exogenous pathogen challenge also occurs. Upon activation by exogenous antigens in the periphery the B cell repertoire is further diversified by processes of somatic hypermutation (SHM), class switch recombination (CSR) and affinity maturation of the rearranged Ig genes. Due to the constant selection pressures on the B cell repertoire, the quality and diversity of IGH, IGK and IGL repertoires may reflect B-cell development [2] [3] [4] , the history of antigen challenge [5, 6] , the ageing process [7, 8] and many pathological conditions [9, 10] .
In light of the complexity of the BCR repertoire and its enormous diversity, it has previously been difficult to analyse it in great detail. Initially, a polymerase chain reaction (PCR)-based method that amplifies the Ig gene fragment across the CDR-H3 region, termed CDR-H3 spectratype analysis, made it possible to examine the global changes of BCR repertoires with ageing [9] and in response to vaccination [6] . CDR-H3 spectratyping has also been a useful tool to detect expansion of a particular clone such as seen in lymphomas. However, it is limited to the measurement of CDR-H3 sizes and cannot provide additional information on BCR repertoires, e.g. the usage of different Ig genes, the extent of hypermutation and the exact sequence of CDR-H3. Although the traditional Sanger sequencing technique can overcome the limitations of CDR-H3 spectratyping with respect to detailed information, it does not have the advantage that spectratyping has, of being able to easily look at sufficient numbers of Ig sequences with the coverage that could reflect the diversity of BCR repertoire in humans. With the advance in next generation sequencing (NGS) technologies, several platforms are developed, capable of producing large numbers of reads that Sanger sequencing techniques cannot deliver [11] . Currently, there are two main competitors in NGS technologies: Illumina and Roche 454 platforms. As compared with the Illumina MiSeq platform that has a capacity of 15x10 6 reads per run with a maximum read length of 250 bp, the upgraded Roche 454 GS FLX+ system is able to produce long-read sequences up to 1000 bp albeit with a smaller coverage of 1 x10 6 reads per run. Since the length of an Ig gene from the beginning of the Ig gene, through the CDR-H3 region, to the constant region is 400 to 500 bp, the longer read length makes the 454 GS FLX+ system ideal for high-throughput sequencing (HTS) of human Ig genes. By incorporating Multiplex Identifier (MID)-containing adaptors into 454 NGS technology, several BCR repertoire libraries can be multiplexed in order to reduce the cost [12] .
We have previously used CDR-H3 spectratype analysis in conjunction with HTS techniques on the 454 GS FLX Titanium system to demonstrate temporal and agerelated changes in human peripheral blood IGH repertoires in response to vaccination [6, 7] . We have also shown that IGH repertoires in different B cell subsets can be distinguished from one another by HTS techniques [13, 14] . Here we describe detailed protocols for CDR-H3 spectratyping on the ABI 3730xl DNA Analyzer system and HTS from IGH and IGK or IGL repertoires on the 454 GS FLX Titanium system using human cDNA.
Materials
Analyses of gene families by methods that use PCR are particularly at risk of cross contamination, especially if the targets are limited such as in single cell analyses. UVisolation cabinets should be used and different steps should be carried out in different areas of the lab, or in different rooms, wherever possible. A DNA/RNA-free UV isolation hood with dedicated pipettes should be reserved for preparation of Sort-Lysis Reverse 
Spectratype analysis of human immunoglobulin CDR-H3 regions
Spectratype analysis allows investigation of BCR repertoires by measuring relative quantities of different sizes of CDR-H3 regions. It is relatively cheap and quick compared to HTS techniques. If HTS is employed the information will be in the sequencing data and spectratyping will not be necessary. This section includes generation of PCR products, which span across human immunoglobulin CDR-H3 regions and into the 5'-end of the constant region ( Figure 1 ), and preparation of samples prior to fragment size analysis on the Applied Biosystems 3730xl DNA Analyzer system. 1. Assemble reagents for PCR master mix and vortex to mix thoroughly. Change the 3'-end primer for different isotypes of the heavy chains. The concentration for each reagent is shown in Table 3 . The concentration for each reagent is shown in Table 5 . Table 6 . Table 7 . 1.2e. Seal PCR plates with thermal seals and carry out the PCR2 reaction on the thermal cycler programmed as in Table 8 . Separate DNA fragments by electrophoresis at 100V for 60 minutes. 7. Visualise DNA fragments using the DarkReader 46B Transilluminator instrument. 8. Excise fragments of the right size (Figure 3 ), using sterile scalpels and transfer gel slices into 15 ml Falcon tubes. 9. Extract DNA using the QIAquick gel purification kit, according to the manufacturer's instructions, except for the following changes:
9a. Incubate gel slices in 5 ml of Buffer QG per amplicon type in 15 ml Falcon tubes at 55 o C. Vortex frequently until gel slices are melted. Expect approximately 6ml of the solutions in total per amplicon type in the 15 ml Falcon tube. 9b. Use one QIAquick spin column per amplicon type: apply 750 µl of the solution to the QIAquick spin column and centrifuge at 13,000 rpm for 30 seconds. Collect, rather than discard, the flow-through in a separate 15 ml Falcon tube.
Repeat this process until all mixture has been applied to the same column, spun and recollected in a separate 15 ml Falcon tube. 9c. Apply the flow-through (750 µl at a time) back to the same spin column, spin at 13,000 rpm and discard the second flow through. 9d. Wash the spin column with 750 µl Buffer PE by centrifuging at 13,000 rpm for 1 minute. 9e. Add 55 µl PCR-grade H 2 O to the column membrane and leave at RT for 3 minutes. 9f. Centrifuge the column at 13,000 rpm for 1 minute and collect the elution in 1.5 ml microcentrifuge tube. 9g. Add additional 55 µl of PCR-grade water to the same column membrane and leave at RT for 3 minutes. 9h. Spin to collect the elution in the same 1.5 ml microcentrifuge tube. In total, approximately 100 µl of elution will be collected in one 1.5ml microcentrifuge tube. 10. Measure the concentration and quality of the gel-purified products for each amplicon type using the Qubit dsDNA HS Assay Kits on the Qubit 2.0 Fluorometer. 11. Assemble the multiple amplicons into one sequencing sample.
When 12 MID barcodes are used, transfer 900 ng of products per MID to a clean 1.5 ml microcentrifuge tube, i.e. a total of 10,800 ng are pooled from 12 MID types (See Note 14). If amplicons of multiple isotypes of heavy chain and light chains are allocated to the same MID barcode, divide 900 ng equally. Examples for the amount (in ng) of gel-purified products for pooling multiple amplicon types are listed in Table 9 . NA  450  900  MID 6  225  225  225  NA  225  900  MID 7  180  180  180  180  180  900  MID 8  180  180  180  180  180  900  MID 9  180  180  180  180  180  900  MID 10  180  180  180  180  180  900  MID 11  180  180  180  180  180  900  MID 12  180  180  180  180  180 900 Total = 10,800 ng per 1/16 th microtitre chip 12. Enrich pooled products using the QIAquick PCR purification kit, according to the manufacture's instructions. This step is carried out in a similar way as Step 9, except Buffer PBI is used to mix with the pooled gel-purified solutions. Elute products in two lots of 55 µl PCR-grade water as Step 9. 13. Measure the concentration and quantity of the pooled mixture as Step 10. The pooled mixture for the final sequencing sample needs to be a total of at least 5 g at a concentration of 100 ng/µl.
14. Analyse 100 ng of the final sequencing sample on 1.5% agarose/TAE/EtBr gel to check that all primers have been removed before HTS is carried out. Samples are sent for sequencing according to the instructions from the contractor (LGC Genomics). 15. Sequence data are output as the .FASTA format and the raw FASTA files are analysed in a three-stage approach [6, 15] . 15a. First, individual potential IGH sequences are subjected to a series of quality control (QC) assessments with the aim of identifying sequences that implausible from a biological perspective (for example, an interval between the two Ig primers that is too short based on known Ig gene sequences, or an arrangement or spacing of internal Ig motifs that is incompatible with known Ig gene sequences), contain evidence of PCR or library construction artefacts (such as internal MID sequences, or mis-matches between the start and finish MID motifs), or are too short to provide data on isotype or CDR-H3 region. Sequences that fail this initial QC step are excluded from further analysis. 15b. Sequences that pass this quality control are then edited to remove any terminal adapter and MID sequences added as part of the sequencing protocol, and each sequence is re-named so as to capture and embed sample information based on the MID tag. Sequences are then passed in bulk to HighV-QUEST [16, 17] . This is a freely available online resource (http://www.imgt.org/HighV-QUEST/index.action) that analyses each sequence with reference to a database of human Ig sequences and returns a summary file cataloguing a range of outputs for each sequence including V, D and J gene usage and CDR-H3 sequence and length. 15c. The V-QUEST output file is then parsed locally to further summarise the data for each sequence regarding gene usage. The amino acid sequence of the CDR-H3 junction peptide is extracted and analysed for a range of physicochemical properties (hydrophobicity, charge, amino acid use, and so forth) using a locally scripted version of the ProtParam tool that is available on the ExPASy server [18] . In addition, the DNA sequence of the CDR3 region is used, in combination with hierarchical clustering and tree cutting, to identify clusters ("clones") of sequences that share related CDR-H3 sequences. Further analysis highlights clones that span multiple isotypes (indicative of class switching). Finally, a single sequence from each clone is identified that represents the most common pattern of gene usage as a reference sequence for further analysis, such as regarding overall repertoire (See Note 15).
Notes
1. At low cell numbers this is not an issue but if high cell numbers (over 6,000 cells) are used, the subsequent PCR steps may be more efficient if the cDNA sample synthesised using SLyRT buffer is diluted 1 in 3 (35 µl + 70 µl) with PCR grade water. 2. 100% Triton is difficult to pipette due to high viscosity so it may be helpful to cut the end of the pipette tip with a scalpel to make it wider, and pipette slowly.
3. Add 200 μl each of dATP, dTTP, dCTP, dGTP in (20 mM each; Promega, UK) to 200 μl DNase/RNase-free H 2 O and vortex to mix. 4. 1X TAE running buffer contained 40 mM Tris-borate and 1 mM EDTA. To make 50x TAE, 242 g Tris base, 57.1 ml glacial acetic acid (Merck, UK) and 100 ml EDTA (pH 8.0) were dissolved in 1 litre distilled water, and then filtered to sterilise. 1 volume of 50x TAE was then diluted with 49 volumes of distilled water to make 1x TAE. 5. To make 6X Orange loading dye, add 0.25 g Orange G (Sigma Aldrich, UK) to 30 ml glycerol and 70 ml distilled water in a 50 ml Falcon tube and vortex to mix thoroughly. 6. Primers for spectratyping are listed in Table 10 below. polyacrylamide gels to check before running on the analyser. 9. FW3-FAM primers are light sensitive and should avoid exposure to the light.
PCR products for spectratyping should not be kept in the fridge longer than 3 days before analysis, as the signals from the 3730xl DNA Analyzer system could be reduced. 10. The primers for the C regions in the different isotypes do not all bind at the same distance away from the joining region. Therefore a correction will need to be applied to normalise the data. To get the actual CDR-H3 size without primer sequences, subtract 70bp (IGHM primers) or 146bp (IGHG primers) or 126bp (IGHA primers). 11. An example of experimental organisation for HTS samples is shown in Table  11 , where 12 research samples are multiplexed as one sequencing sample. (Table 13 ). The gene specific sequences of 5'-end primers for the heavy and light chains and 3'-end primers for the light chains are same as PCR1. The genespecific sequences in the 3'-end primers of the heavy chains anneal for PCR2 reactions (Table 14) to the template more upstream to those used in PCR1. Table  14 Sequence (5' to 3') IGHA'' GGAAGAAGCCCTGGACCAGGC IGHG'' CACCGTCACCGGTTCGGGG IGHM'' CAGGAGACGAGGGGGAAAAGG For space consideration, MID1-containing primers for IgA are shown as an example (Table 15) . Although it only requires 5 ng (50ng/μl) in total of the purified pooled mixture to be sequenced as one sequencing sample using a 1/16 th microchip on the 454 GS FLX Titanium platform, a significant amount of products can be lost during the gel purification and enrichment steps. It is therefore ideal to prepare more products than 5 ng in total before gel purification and enrichment steps and then dilute final sequencing sample to the concentration of 50ng/μl.
15. All the analyses (other than online submission to HighV-Quest) are performed using custom scripts written in the open-source R language [19] using additional packages, notable Biostrings, from the Bioconductor project [20] . All the R/Bioconductor packages are open source and freely available. A full work flow, including custom R scripts to perform the pre-V-QUEST quality control filtering and editing, the parsing of the V-QUEST output files and ProtParam analysis, and the clustering-based clone identification, is available from the authors (KiplingD@cardiff.ac.uk) upon request. 
